Gritstone Bio Inc (NASDAQ:GRTS) price closed lower on Monday, April 15, dropping -12.15% below its previous close.
A look at the daily price movement shows that the last close reads $0.84. The company’s 5Y monthly beta was ticking 0.43. Taking into account the 52-week price action we note that the stock hit a 52-week high of $3.33 and 52-week low of $0.83. The stock subtracted -67.01% on its value in the past month.
Gritstone Bio Inc, which has a market valuation of $78.62 million, is expected to release its quarterly earnings report May 09, 2024 – May 13, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give GRTS a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 50% Sell.
The overview shows that GRTS’s price is at present -61.04% off the SMA20 and -65.51% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 24.06, with weekly volatility standing at 10.52%. The indicator jumps to 10.71% when calculated based on the past 30 days. Gritstone Bio Inc (NASDAQ:GRTS)’s beta value is holding at 0.58, while the average true range (ATR) indicator is currently reading 0.22.
An analysis of the Gritstone Bio Inc (NASDAQ:GRTS) stock in terms of its daily trading volume indicates that the 3-month average is 2.88 million.
Current records show that the company has 97.59M in outstanding shares. The insiders’ percentage holdings are 8.58% of outstanding shares while the percentage share held by institutions stands at 35.49%. But the -63.78% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
